Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,574,926
Closed -$25.4M 319
2016
Q4
$25.4M Sell
1,574,926
-31,566
-2% -$436K 1.28% 9
2016
Q3
$20.1M Sell
1,606,492
-13,819
-0.9% -$158K 1.05% 27
2016
Q2
$15.9M Sell
1,620,311
-18,260
-1% -$188K 0.92% 43
2016
Q1
$20.4M Sell
1,638,571
-4,073
-0.2% -$43.2K 1.18% 19
2015
Q4
$20.4M Sell
1,642,644
-18,237
-1% -$249K 1.17% 19
2015
Q3
$24.1M Sell
1,660,881
-2,370
-0.1% -$33.8K 1.56% 8
2015
Q2
$20.7M Buy
1,663,251
+14,496
+0.9% +$181K 1.2% 19
2015
Q1
$20M Sell
1,648,755
-23,152
-1% -$257K 1.16% 16
2014
Q4
$18.8M Buy
+1,671,907
New +$16.4M 1.14% 24

Other funds holding XXIA

Rice Hall James & Associates's XXIA Position: Q1 2017 in Review

Rice Hall James & Associates sold out of Ixia (XXIA) in Q1 2017, closing a stake of 1,574,926 shares — an estimated $25.4M sold.

Rice Hall James & Associates first reported a position in XXIA in Q4 2014 and held it in 9 quarters. The position peaked at $25.4M in Q4 2016. 140 funds tracked by Wall St. Rank hold XXIA as of Q1 2017.

  • Rice Hall James & Associates reported no remaining Ixia position as of Q1 2017 after selling out during the quarter.
  • Rice Hall James & Associates sold 1,574,926 Ixia shares in Q1 2017, an estimated $25.4M.
  • Rice Hall James & Associates first reported a position in Ixia in Q4 2014 and held it in 9 quarters.
  • Rice Hall James & Associates's Ixia position peaked at $25.4M in Q4 2016.
  • 140 funds tracked by Wall St. Rank held Ixia as of Q1 2017.

Based on Rice Hall James & Associates's 13F filing for Q1 2017, filed 19 Apr 2017.